Physician profile
James D Mitchell
NPI 1902026909
$32,086.66
in general payments reported to CMS, 2019-2025
16 companies · $10K in 2025
The $10K reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,846 · 2020: $334 · 2021: $3,566 · 2022: $6,541 · 2023: $1,802 · 2024: $7,863 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $4,818 · Travel and Lodging: $3,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,425.00 |
| Food and Beverage | $4,817.51 |
| Travel and Lodging | $3,557.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $8,350.86 | 2019-2023 | Insitu Hip System |
| Linkbio Corp | $8,330.99 | 2023-2025 | |
| Total Joint Orthopedics, INC. | $4,145.03 | 2022-2025 | |
| Stryker Corporation | $3,353.61 | 2019-2025 | Mako, Insignia, Gmrs |
| Medacta USA, INC. | $2,709.50 | 2025 | Gmk Sphere, Amistem, Spherika |
| Zimmer Biomet Holdings, INC. | $1,464.66 | 2021 | |
| Maxx Orthopedics, INC. | $1,130.62 | 2023 | |
| Smith+Nephew, INC. | $922.90 | 2021-2025 | Evos, Maverick, Capture |
| Microport Orthopedics INC | $778.20 | 2024-2025 | Mpo Medial Pivot Knee, Mpo Hip System |
| Encore Medical, Lp | $564.16 | 2025 | Djo Surgical |
| Omnilife Science, INC | $158.89 | 2019 | |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Innovation Technologies INC | $49.73 | 2023-2024 | Irrisept |
| Si-Bone, INC. | $26.87 | 2023 | |
| Spectrum Pharmaceuticals INC. | $22.01 | 2024 | Rolvedon |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.18 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.